Over the last 7 days, the Biotech industry has dropped 5.4%, driven by a pullback from Swedish Orphan Biovitrum of 8.0%. In contrast, BioArctic has gained 9.1%. This takes the industry's 12 month performance to a gain of 18%. Looking forward, earnings are forecast to grow by 47% annually.
Has the Swedish Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 04 Aug 2024 | SEK 194.1b | SEK 31.4b | -SEK 5,420,171,537.87 | 43.2x | -35.8x | 6.2x |
Tue, 02 Jul 2024 | SEK 198.1b | SEK 30.6b | -SEK 5,538,305,654.58 | 39.6x | -35.8x | 6.5x |
Thu, 30 May 2024 | SEK 187.6b | SEK 30.6b | -SEK 5,439,985,741.34 | 38.7x | -34.5x | 6.1x |
Sat, 27 Apr 2024 | SEK 183.6b | SEK 30.8b | -SEK 5,532,366,350.26 | 50.9x | -33.2x | 6x |
Mon, 25 Mar 2024 | SEK 184.6b | SEK 29.8b | -SEK 5,636,766,957.11 | 58.7x | -32.8x | 6.2x |
Wed, 21 Feb 2024 | SEK 181.9b | SEK 29.7b | -SEK 5,699,147,445.67 | 52x | -31.9x | 6.1x |
Fri, 19 Jan 2024 | SEK 187.2b | SEK 28.7b | -SEK 1,200,630,757.00 | 58.7x | -155.9x | 6.5x |
Sun, 17 Dec 2023 | SEK 196.9b | SEK 28.7b | -SEK 1,170,293,890.00 | 60.4x | -168.2x | 6.9x |
Tue, 14 Nov 2023 | SEK 161.9b | SEK 28.7b | -SEK 1,235,295,198.00 | 50.4x | -131x | 5.6x |
Thu, 12 Oct 2023 | SEK 158.0b | SEK 27.4b | -SEK 1,998,092,799.00 | 49x | -79.1x | 5.8x |
Sat, 09 Sep 2023 | SEK 150.4b | SEK 27.4b | -SEK 1,977,430,828.00 | 47x | -76.1x | 5.5x |
Mon, 07 Aug 2023 | SEK 153.8b | SEK 27.5b | -SEK 1,574,427,530.00 | 54.3x | -97.7x | 5.6x |
Wed, 05 Jul 2023 | SEK 164.3b | SEK 26.4b | -SEK 1,317,403,736.00 | 45.9x | -124.7x | 6.2x |
Fri, 02 Jun 2023 | SEK 166.0b | SEK 26.4b | -SEK 1,239,415,527.00 | 45.2x | -133.9x | 6.3x |
Sun, 30 Apr 2023 | SEK 175.8b | SEK 26.3b | -SEK 1,262,253,450.00 | 45.6x | -139.3x | 6.7x |
Tue, 28 Mar 2023 | SEK 164.6b | SEK 25.4b | -SEK 2,015,394,373.00 | 39.2x | -81.7x | 6.5x |
Thu, 23 Feb 2023 | SEK 171.3b | SEK 25.4b | -SEK 2,116,252,586.00 | 39.4x | -80.9x | 6.7x |
Sat, 21 Jan 2023 | SEK 176.8b | SEK 23.8b | -SEK 1,839,311,016.00 | 32.2x | -96.1x | 7.4x |
Mon, 19 Dec 2022 | SEK 158.6b | SEK 23.8b | -SEK 1,838,013,390.00 | 31.2x | -86.3x | 6.7x |
Wed, 16 Nov 2022 | SEK 160.7b | SEK 23.9b | -SEK 1,905,280,230.00 | 32.4x | -84.3x | 6.7x |
Fri, 14 Oct 2022 | SEK 151.8b | SEK 22.9b | -SEK 3,333,690,929.00 | 30x | -45.5x | 6.6x |
Sun, 11 Sep 2022 | SEK 159.5b | SEK 22.9b | -SEK 3,243,830,491.00 | 34x | -49.2x | 7x |
Tue, 09 Aug 2022 | SEK 170.2b | SEK 22.7b | -SEK 3,505,225,617.00 | 35.3x | -48.6x | 7.5x |
Thu, 07 Jul 2022 | SEK 160.2b | SEK 21.4b | -SEK 3,520,755,766.00 | 37.3x | -45.5x | 7.5x |
Sat, 04 Jun 2022 | SEK 158.7b | SEK 21.4b | -SEK 3,525,233,201.00 | 44.4x | -45x | 7.4x |
Mon, 02 May 2022 | SEK 153.5b | SEK 21.3b | -SEK 3,495,520,997.00 | 46x | -43.9x | 7.2x |
Wed, 30 Mar 2022 | SEK 169.5b | SEK 19.7b | -SEK 3,081,311,630.00 | 50.5x | -55x | 8.6x |
Fri, 25 Feb 2022 | SEK 153.9b | SEK 19.6b | -SEK 2,694,708,673.00 | 48.4x | -57.1x | 7.9x |
Sun, 23 Jan 2022 | SEK 168.7b | SEK 19.1b | -SEK 2,041,717,712.00 | 50.4x | -82.6x | 8.8x |
Tue, 21 Dec 2021 | SEK 192.2b | SEK 19.0b | -SEK 1,992,555,850.00 | 51.9x | -96.5x | 10.1x |
Thu, 18 Nov 2021 | SEK 202.1b | SEK 19.0b | -SEK 1,429,394,266.00 | 54.8x | -141.4x | 10.7x |
Sat, 16 Oct 2021 | SEK 199.5b | SEK 18.1b | -SEK 1,345,754,716.00 | 47.3x | -148.2x | 11x |
Mon, 13 Sep 2021 | SEK 216.7b | SEK 18.1b | -SEK 1,339,275,285.95 | 52.4x | -161.8x | 12x |
Wed, 11 Aug 2021 | SEK 193.5b | SEK 18.1b | -SEK 1,175,418,285.95 | 53.2x | -164.6x | 10.7x |
-164.6x
Which industries have driven the changes within the Swedish Healthcare industry?
SE Market | -4.24% | |
Healthcare | -3.96% | |
Biotech | -5.36% | |
Biotech | -5.36% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
BIOA B BioArctic | SEK 159.00 | 9.1% +SEK 1.2b | -46.4% | PS55.7x | |
ALZ Alzinova | SEK 3.88 | 52.8% +SEK 59.7m | 14.6% | PS9.6x | |
SANION Saniona | SEK 4.86 | 10.3% +SEK 50.6m | -47.3% | PS26.1x | |
ISOFOL Isofol Medical | SEK 2.32 | 15.4% +SEK 50.1m | 269.4% | PB3.3x | |
LIPUM Lipum | SEK 12.00 | 14.3% +SEK 31.8m | 34.2% | PS4802.8x |